Top Markets
Coin of the day
Avenir Wellness Solutions, Inc. Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc.

AVRW
Rang in aandelen #41549
Avenir Wellness Solutions, Inc., operating through its subsidiary The Sera... Avenir Wellness Solutions, Inc., operating through its subsidiary The Sera Labs, Inc., specializes in crafting advanced nutraceutical formulations and innovative delivery technologies. Their objective is to maximize product effectiveness and enhance overall well-being. The company offers a diverse range of products across the beauty, health and wellness, and pet care segments, sold under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brands. Distribution channels include major drugstores, supermarkets, convenience stores, and mass retailers. Additionally, Avenir Wellness Solutions supplies products under private labels to other retailers and multi-level marketing firms, and directly to consumers online, including through subscription services. Established in 2014, the company was formerly known as CURE Pharmaceutical Holding Corp. before adopting its current name in October 2022. Its corporate headquarters are located in Sherman Oaks, California.
Aandeelprijs
$0.0002
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$16.62K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-93.33%
Land
US
Handel Avenir Wellness Solutions, Inc. (AVRW)
Winst voor Avenir Wellness Solutions, Inc. (AVRW)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Avenir Wellness Solutions, Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Avenir Wellness Solutions, Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$12.96B -
CH
- -
FR
- -
JP
$550.06M -
IN
- -
BR